These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 25413068)

  • 1. [Amiloride reduces proteinuria and inhibits podocyte uPAR in the 5/6 nephrectomy rats].
    He C; Zhang B; Xie S; Yang Y; Ma J; Shi W
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Nov; 34(11):1654-7. PubMed ID: 25413068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amiloride off-target effect inhibits podocyte urokinase receptor expression and reduces proteinuria.
    Zhang B; Xie S; Shi W; Yang Y
    Nephrol Dial Transplant; 2012 May; 27(5):1746-55. PubMed ID: 22076430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,25-dihydroxyvitamin D(3) inhibits podocyte uPAR expression and reduces proteinuria.
    Ma J; Zhang B; Liu S; Xie S; Yang Y; Ma J; Deng Y; Wang W; Xu L; Li R; Zhang L; Yu C; Shi W
    PLoS One; 2013; 8(5):e64912. PubMed ID: 23741418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiloride, a urokinase-type plasminogen activator receptor (uTPA) inhibitor, reduces proteinurea in podocytes.
    Xu LB; Chi N; Shi W
    Genet Mol Res; 2015 Aug; 14(3):9518-29. PubMed ID: 26345885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [11R-VIVIT inhibits the expression of urokinase-type plasminogen activator receptor in podocytes].
    Li R; Shi W; Ma J; Zhang B; Zhang L; Liang X; Chen Y; Liu S; Wang W
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jul; 33(7):1022-6. PubMed ID: 23895845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil alleviates lupus nephritis through urokinase receptor signaling in a mice model.
    Cheng CC; Lee YF; Lan JL; Wu MJ; Hsieh TY; Lin NN; Wang JM; Chiu YT
    Lupus; 2013 May; 22(6):554-61. PubMed ID: 23478030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapamycin promotes podocyte migration through the up-regulation of urokinase receptor.
    Wu MJ; Chang CH; Shu KH; Ho HC; Li JR; Fu YC
    Transplant Proc; 2014 May; 46(4):1226-8. PubMed ID: 24815166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury.
    Zhang B; Shi W; Ma J; Sloan A; Faul C; Wei C; Reiser J; Yang Y; Liu S; Wang W
    J Mol Med (Berl); 2012 Dec; 90(12):1407-20. PubMed ID: 23015147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Podocyte injury: the role of proteinuria, urinary plasminogen, and oxidative stress.
    Raij L; Tian R; Wong JS; He JC; Campbell KN
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1308-F1317. PubMed ID: 27335373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of mineralocorticoid and angiotensin II receptor blockers on proteinuria and glomerular podocyte protein expression in a model of minimal change nephrotic syndrome.
    Fukuda A; Fujimoto S; Iwatsubo S; Kawachi H; Kitamura K
    Nephrology (Carlton); 2010 Apr; 15(3):321-6. PubMed ID: 20470301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of kidney barrier function by the urokinase receptor.
    Wei C; Möller CC; Altintas MM; Li J; Schwarz K; Zacchigna S; Xie L; Henger A; Schmid H; Rastaldi MP; Cowan P; Kretzler M; Parrilla R; Bendayan M; Gupta V; Nikolic B; Kalluri R; Carmeliet P; Mundel P; Reiser J
    Nat Med; 2008 Jan; 14(1):55-63. PubMed ID: 18084301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the knockdown of Cabin1 on p53 in glomerular podocyte.
    Wen Y; Zhou P; Liu L; Wang Z; Zhang Y; Liang J
    J Recept Signal Transduct Res; 2016; 36(2):173-80. PubMed ID: 26400065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knocking down Cabin1 induces glomerular podocyte injury.
    Wen Y; Liu L; Xu Q; Zhou P; Li H; Wang Z; Liang J
    Int Urol Nephrol; 2018 May; 50(5):983-991. PubMed ID: 29368245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1.
    Shibata S; Nagase M; Yoshida S; Kawachi H; Fujita T
    Hypertension; 2007 Feb; 49(2):355-64. PubMed ID: 17200434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant glomerular filtration of urokinase-type plasminogen activator in nephrotic syndrome leads to amiloride-sensitive plasminogen activation in urine.
    Stæhr M; Buhl KB; Andersen RF; Svenningsen P; Nielsen F; Hinrichs GR; Bistrup C; Jensen BL
    Am J Physiol Renal Physiol; 2015 Aug; 309(3):F235-41. PubMed ID: 25972510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extract of Rhizoma Polygonum cuspidatum reduces early renal podocyte injury in streptozotocin‑induced diabetic rats and its active compound emodin inhibits methylglyoxal‑mediated glycation of proteins.
    Sohn E; Kim J; Kim CS; Jo K; Kim JS
    Mol Med Rep; 2015 Oct; 12(4):5837-45. PubMed ID: 26299942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
    Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rostafuroxin protects from podocyte injury and proteinuria induced by adducin genetic variants and ouabain.
    Ferrandi M; Molinari I; Rastaldi MP; Ferrari P; Bianchi G; Manunta P
    J Pharmacol Exp Ther; 2014 Nov; 351(2):278-87. PubMed ID: 25187430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production.
    Toyonaga J; Tsuruya K; Ikeda H; Noguchi H; Yotsueda H; Fujisaki K; Hirakawa M; Taniguchi M; Masutani K; Iida M
    Nephrol Dial Transplant; 2011 Aug; 26(8):2475-84. PubMed ID: 21220752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enalapril in subantihypertensive dosage attenuates kidney proliferation and functional recovery in normotensive ablation nephropathy of the rat.
    Krivosíková Z; Sebeková K; Spustová V; Lajdová I; Dzúrik R
    Physiol Res; 1999; 48(6):429-35. PubMed ID: 10783907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.